OS Therapies Inc (OSTX) stock
OSTXNYSEPharmaceutical PreparationsFiscal year ends December 31
$0.74−0.01 (-0.68%)
Close on Nov 13, 2026Market cap $34.36MP/E –Yield –
Earnings
OS Therapies's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Next report
–
Not yet scheduled
Revenue, Q2 FY2025
–
EPS, Q2 FY2025
-$0.19
-$0.26 a year earlier
Latest guidance
None
No outlook given in releases
Quarterly results
Revenue and earnings per share from each of OS Therapies's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Source |
|---|---|---|---|---|---|
| Q2 FY2025ended Jun 30, 2025 | Aug 19, 2025before the open | – | – | -$0.19 | Release |
| Q1 FY2025ended Mar 31, 2025 | May 16, 2025after the close | – | – | -$0.18 | Release |
| Q4 FY2024ended Dec 31, 2024 | Mar 31, 2025after the close | – | – | – | Release |
| Q3 FY2024ended Sep 30, 2024 | Nov 15, 2024after the close | – | – | -$0.18 | Release |
| Q2 FY2024ended Jun 30, 2024 | Aug 15, 2024after the close | – | – | -$0.26 | Release |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Guidance
OS Therapies has not given guidance in its releases
Many companies give their outlook only on the conference call or not at all. When OS Therapies puts a forecast in an earnings release, it is listed here with the exact sentence.
Press releases
Releases OS Therapies filed with the SEC as exhibits to Form 8-K or 6-K
- News
- News
- News
- Update
- Update
- News
- News
- Update
- News
- News
- Results
- News
- News
- Results
- News
See a number that looks wrong?